Home›Search›Expert Opinion on Investigational Drugs

Expert Opinion on Investigational Drugs

Taylor and Francis Ltd. · United Kingdom · Est. 1968

ISSN1354-3784eISSN1744-7658

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

Total60

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.267

H-Index

131

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.898

Total Works

5,089

Total Citations

134,450

2yr Mean Citedness

3.73

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal focuses on the evaluation of novel therapeutic agents and treatment strategies across a range of diseases, including various cancers, autoimmune disorders, neurodegenerative conditions, and psychiatric disorders. Articles review preclinical and clinical data, discuss mechanisms of action, and explore challenges and future directions for drug development and patient management.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 25% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1968

FrequencyMonthly

StatusActive (last: 2026)

Total Publications5,089

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1354-3784 / 1744-7658

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q1

PharmacologyQ1

Pharmacology (medical)Q1

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Medicine (miscellaneous)

Research Topics (OpenAlex)

Monoclonal and Polyclonal Antibodies ResearchDiabetes Treatment and ManagementAsthma and respiratory diseasesLipoproteins and Cardiovascular HealthHIV/AIDS drug development and treatmentHER2/EGFR in Cancer ResearchNeurotransmitter Receptor Influence on BehaviorImmunotherapy and Immune ResponsesCancer Treatment and PharmacologyAngiogenesis and VEGF in Cancer